Merck & Co Inc
BMV:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
BMV:MRK
|
US |
|
Akari Therapeutics PLC
F:CLA
|
US |
|
C
|
Coterra Energy Inc
XMUN:XCQ
|
US |
|
P
|
PennantPark Floating Rate Capital Ltd
NYSE:PFLT
|
US |
Wall St Price Targets
MRK Price Targets Summary
Merck & Co Inc
According to Wall Street analysts, the average 1-year price target for
MRK is 2 306.6881 MXN with a low forecast of 1 760.0448 MXN and a high forecast of 2 836.1118 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRK's stock price target?
Price Target
2 306.6881
MXN
According to Wall Street analysts, the average 1-year price target for
MRK is 2 306.6881 MXN with a low forecast of 1 760.0448 MXN and a high forecast of 2 836.1118 MXN.
What is the Revenue forecast for Merck & Co Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Merck & Co Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Merck & Co Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 10%.
What is the Pre-Tax Income forecast for Merck & Co Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 15%.
What is the Net Income forecast for Merck & Co Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 14%.